CONTRAFECT CORP
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
You can watch CFRXQ and buy or sell other stocks, ETFs, and their options commission-free!About CFRXQ
ContraFect Corp. is a clinical stage biotechnology company, which engages in the discovery and development of direct lytic agents (DLAs), including lysins and amurin peptides, as new medical modalities for the treatment of life-threatening, antibiotic-resistant infections. Its product pipeline consists of CF-301, Gram-Negative Lysins, and Amurin Peptides.
CEOMichael Messinger, CPA
CEOMichael Messinger, CPA
Employees23
Employees23
HeadquartersYonkers, New York
HeadquartersYonkers, New York
Founded2008
Founded2008
Employees23
Employees23
CFRXQ Key Statistics
Market cap1.07K
Market cap1.07K
Price-Earnings ratio—
Price-Earnings ratio—
Dividend yield—
Dividend yield—
Average volume463.00
Average volume463.00
High today—
High today—
Low today—
Low today—
Open price—
Open price—
Volume0.00
Volume0.00
52 Week high$0.0001
52 Week high$0.0001
52 Week low$0.00
52 Week low$0.00
Stock Snapshot
The current CONTRAFECT CORP(CFRXQ) stock price is $0.00, with a market capitalization of 1.07K.
During the trading day, CONTRAFECT CORP(CFRXQ) stock saw an opening price of —, a peak of —, and a bottom of —.
Trading volume for CONTRAFECT CORP(CFRXQ) stock has reached 0, versus its average volume of 463.
Over the past 52 weeks, CONTRAFECT CORP(CFRXQ) stock has traded between a high of $0.00 and a low of $0.00.
Over the past 52 weeks, CONTRAFECT CORP(CFRXQ) stock has traded between a high of $0.00 and a low of $0.00.
People also own
Based on the portfolios of people who own CFRXQ. This list is generated using Robinhood data, and it’s not a recommendation.